Evolent Health, Inc. (EVH) Files Form 4 Insider Selling : Board Co Advisory Sells 1,936,529 Shares

Evolent Health, Inc. (EVH): Board Co Advisory , 10% owner of Evolent Health, Inc. sold 1,936,529 shares on Sep 14, 2016. The Insider selling transaction was reported by the company on Sep 14, 2016 to the Securities and Exchange Commission. The shares were sold at $22.50 per share for a total value of $43571904 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Aug 17, 2016, Lydia Stone (Principal Accounting Officer) sold 1,000 shares at $25.66 per share price.On Jun 10, 2015, Gary Piefer (Chief Medical Officer) purchased 2,000 shares at $17.00 per share price.

Evolent Health Inc: On Monday, Sep 12, 2016 heightened volatility was witnessed in Evolent Health Inc which led to swings in the share price. The shares opened for trading at $22.1 and hit $22.85 on the upside , eventually ending the session at $22.78, with a gain of 1.65% or 0.37 points. The heightened volatility saw the trading volume jump to 541,070 shares. The 52-week high of the share price is $26.8392 and the company has a market cap of $1,372 M . The 52-week low of the share price is at $8.14.

Evolent Health Inc Money Flow Index Chart

Company has been under the radar of several Street Analysts.Evolent Health Inc is Reiterated by FBR Capital to Outperform and the brokerage firm has raised the Price Target to $ 26 from a previous price target of $24 .The Rating was issued on Aug 5, 2016.Evolent Health Inc is Initiated by Jefferies to Buy. The Rating was issued on Jul 26, 2016.Evolent Health Inc is Reiterated by FBR Capital to Outperform and the brokerage firm has raised the Price Target to $ 24 from a previous price target of $16 .The Rating was issued on Jul 13, 2016.

Evolent Health Inc. is engaged in the healthcare delivery and payment markets. The Company’s platform enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to value-based payment models. It provides an end-to-end technology-enabled services platform for providers to transition their organization in value-based payment models. It markets and sells services to providers throughout the United States. The Company works with its partners in two phases. In the transformation phase it works with its partners to develop a plan for their transition to a value-based care model. During the second portion of the transformation phase the Company works with its partner to implement the Blueprint. During the transformation phase the Company seeks to enter into long-term agreements with its partners. In the platform and operations phase the Company establishes a local market presence and embeds its resources alongside the Company’s partners.

Leave a Reply

Evolent Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Evolent Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.